Format

Send to

Choose Destination
Clin Pharmacokinet. 2020 Feb;59(2):281-282. doi: 10.1007/s40262-019-00850-5.

Comment on "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Author information

1
Medicines Evaluation Board, Utrecht, The Netherlands. a.yu@cbg-meb.nl.
2
Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands. a.yu@cbg-meb.nl.
3
Medicines Evaluation Board, Utrecht, The Netherlands.
4
Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands.
PMID:
31802403
DOI:
10.1007/s40262-019-00850-5

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center